Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges

by Jingjing Duan, Yu Wang, Shunchang Jiao
Published 2018-09-01

Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer 
with Brain Metastasis

by Qi SONG, Shunchang JIAO, Fang LI
Published 2016-08-01

Case Report: Pseudoprogression With Nivolumab and Bevacizumab Followed by Recurrent Immune-Related Pneumonitis in Urothelial Carcinoma With Lung Metastasis

by Zizhong Yang, Zizhong Yang, Guoqing Zhang, Qiong Sun, Minglu Liu, Jiakang Shao, Shunchang Jiao, Shunchang Jiao
Published 2021-02-01

Clinical Significance of T Lymphocyte Subset Changes After First Line Chemotherapy in Peripheral Blood from Patients with Advanced Stage Adenocarcinoma Cell Lung Cancer

by Xiang YAN, Xiao ZHAO, Shunchang JIAO, Shengjie SUN, Liangliang WU, Zhiyong WU
Published 2012-03-01

Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in A...

by Ye Li, Ye Li, Ye Li, Jiaqian Wang, Jiaqian Wang, Liangliang Wu, Xiaoting Li, Xiaoting Li, Xiaoyun Zhang, Guoqing Zhang, Shengqiang Xu, Shengqiang Xu, Shengjie Sun, Shunchang Jiao, Shunchang Jiao
Published 2021-06-01

Predictive Biomarkers of Dicycloplatin Resistance or Susceptibility in Prostate Cancer

by Minglu Liu, Xiaoyu Zhou, Jun Liu, Chelong Lu, Guoqing Zhang, Jing Zhang, Shunchang Jiao
Published 2021-07-01

The role of miR-485-5p/NUDT1 axis in gastric cancer

by Jingjing Duan, Haiyang Zhang, Shuang Li, Xinyi Wang, Haiou Yang, Shunchang Jiao, Yi Ba
Published 2017-10-01

Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta‐analysis

by Zhibo Zhang, Ye Li, Xiang Yan, Qi Song, Guoqiang Wang, Yi Hu, Shunchang Jiao, Jinliang Wang
Published 2019-04-01

miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1

by Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin Chen, Yameng Xu, Shunchang Jiao
Published 2018-12-01

A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy

by Jingjing Duan, Yongwei Xie, Lijuan Qu, Lingxiong Wang, Shunkai Zhou, Yu Wang, Zhongyi Fan, Shengsheng Yang, Shunchang Jiao
Published 2018-10-01

Prognostic Significance of Tumor-infiltrating CD8 + or CD3 + T Lymphocytes and Interleukin-2 Expression in Radically Resected Non-small Cell Lung Cancer

by Chuntao Tian, Shixin Lu, Qingxia Fan, Weijie Zhang, Shunchang Jiao, Xiao Zhao, Zhiyong Wu, Liang Sun, Liuxing Wang
Published 2015-01-01

Genomic profiling of Chinese patients with urothelial carcinoma

by Bo Yang, Xiao Zhao, Chong Wan, Xin Ma, Shaoxi Niu, Aitao Guo, Jieli Wang, Jinliang Wang, Decong Sun, Shunchang Jiao
Published 2021-02-01

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer

by Yuan‐sheng Zang, Chun Dai, Xiaoman Xu, Xin Cai, Guan Wang, Jinwang Wei, Angela Wu, Wending Sun, Shunchang Jiao, Qiang Xu
Published 2019-08-01

Clinical Activity and Safety of Penpulimab (Anti-PD-1) With Anlotinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: An Open-Label, Multicenter, Phase Ib/II Trial...

by Chun Han, Sisi Ye, Chunhong Hu, Liangfang Shen, Qun Qin, Yuxian Bai, Shizhong Yang, Chunmei Bai, Aimin Zang, Shunchang Jiao, Li Bai
Published 2021-07-01

HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy.

by Li Chen, Yan Shi, Jing Yuan, Yalin Han, Rui Qin, Qian Wu, Baoqing Jia, Bo Wei, Lixin Wei, Guanghai Dai, Shunchang Jiao
Published 2014-01-01

An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway

by Xiaotong Zhang, Gengyi Zou, Xiyang Li, Lun Wang, Tianyu Xie, Jin Zhao, Longlong Wang, Shunchang Jiao, Rong Xiang, Haoyu Ye, Yi Shi
Published 2020-08-01

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)

by Ye Li, Ye Li, Ye Li, Zhibo Zhang, Zhibo Zhang, Zhibo Zhang, Yi Hu, Xiang Yan, Qi Song, Guoqiang Wang, Runzhe Chen, Shunchang Jiao, Jinliang Wang
Published 2020-06-01

Comprehensive analysis of age‐related somatic mutation profiles in Chinese young lung adenocarcinoma patients

by Bo Yang, Jie Li, Fang Li, Hongxia Zhou, Weiwei Shi, Huaiyin Shi, Shengjie Sun, Wending Sun, Jinliang Wang, Junxun Ma, Xiang Yan, Yi Hu, Shunchang Jiao
Published 2019-04-01

The Ratio of IP10 to IL-8 in Plasma Reflects and Predicts the Response of Patients With Lung Cancer to Anti-PD-1 Immunotherapy Combined With Chemotherapy

by Liangliang Wu, Shengzhi Xie, Lingxiong Wang, Jinfeng Li, Lu Han, Boyu Qin, Guoqing Zhang, Qiyan Wu, Wenjuan Gao, Lijun Zhang, Huafeng Wei, Tianyi Liu, Shunchang Jiao
Published 2021-04-01

Efficacy and Toxicity of Pemetrexed or Gemcitabine Combined with Cisplatin in the Treatment of Patients with Advanced Non-small Cell Lung Cancer

by Xingsheng HU, Shunchang JIAO, Shucai ZHANG, Zhehai WANG, Mengzhao WANG, Cheng HUANG, Rongsheng ZHENG, Kai LI, Jie WANG, Yajie WANG, Xuenong OUYANG, Wenguang LV, Gang CHENG, Chunhong HU, Rongcheng LUO, Yan SUN
Published 2012-10-01